Fig. 3: Somatic mutation profiles between younger versus older TCGA patients.
From: Molecular differences between younger versus older ER-positive and HER2-negative breast cancers
a Tumor mutation burden. P-values from Wilcoxon rank-sum test. b Somatic mutation frequency. Only genes with mutation frequency > 5% in both groups are shown. ***Fisher’s exact test p value < 0.0001.
